Insights
Insights on health, access and innovation
Read practical thinking from Newmarket Strategy on the policy, access, reimbursement and health system issues shaping healthcare and life sciences.
I’ve just left the DHSC – ministers still do not know how the NHS will be run next year
The government’s plan to establish temporary NHS regions by April 2027 is looking increasingly uncertain, with key decisions on its structure, leadership and functions still unresolved
Oncology continues to push the boundaries – of both science and HTA
This year’s #ESMO2026 (23-27 Oct) will once again showcase the cutting edge of medical science – bringing excitement for life science enthusiasts and more importantly, hope to increasing numbers of patients
Mismanaged Access? Managed access as a response to regulatory acceleration
Managed access as a response to regulatory acceleration
Part 2: Asset level commercial strategies alongside national level system change
Innovative commercial strategies to achieve an optimal net price have never been more critical – and achieving them will demand a higher appetite for risk from all parties.
Part 1: How to influence national systems to help mitigate MFN headwinds
The UK example demonstrate that national system reform is achievable. But it requires the use of a new playbook.
Newmarket Strategy acquires Visible Analytics to complete its full-service market access offer
Newmarket Strategy, a specialist healthcare and life sciences consultancy, announces today the successful acquisition of Visible Analytics, experts in Health Economics and Outcomes Research (HEOR) and data analytics.
Events
